Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

INTRODUCTION: Netarsudil reduces intraocular pressure (IOP) by increasing aqueous outflow through the trabecular meshwork (TM) pathway and decreasing episcleral venous pressure. The primary objective of this phase 2 study was to evaluate ocular hypotensive efficacy and safety of three netarsudil con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Araie, Makoto, Sugiyama, Kazuhisa, Aso, Kenji, Kanemoto, Koji, Kothapalli, Kalyani, Kopczynski, Casey, Senchyna, Michelle, Hollander, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004483/
https://ncbi.nlm.nih.gov/pubmed/33629227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01634-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados